Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines
Immunological memory is the basis of protective immunity provided by vaccines and
previous infections. Immunological memory can develop from multiple branches of the …
previous infections. Immunological memory can develop from multiple branches of the …
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Abstract Measuring SARS-CoV-2-specific T cell responses is crucial to understanding an
individual's immunity to COVID-19. However, high inter-and intra-assay variability make it …
individual's immunity to COVID-19. However, high inter-and intra-assay variability make it …
[HTML][HTML] Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and …
Multisystem inflammatory syndrome in children (MIS-C) is a severe, hyperinflammatory
disease that occurs after exposure to severe acute respiratory syndrome coronavirus 2 …
disease that occurs after exposure to severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivity
N Benede, MB Tincho, A Walters, V Subbiah, A Ngomti… - Iscience, 2024 - cell.com
SARS-CoV-2 infection in children typically results in asymptomatic or mild disease. There is
a paucity of studies on SARS-CoV-2 antiviral immunity in African children. We investigated …
a paucity of studies on SARS-CoV-2 antiviral immunity in African children. We investigated …
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Epitopes recognized by T cells are a collection of short peptide fragments derived from
specific antigens or proteins. Immunological research to study T cell responses is hindered …
specific antigens or proteins. Immunological research to study T cell responses is hindered …
[HTML][HTML] Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C
Differential host responses in coronavirus disease 2019 (COVID-19) and multisystem
inflammatory syndrome in children (MIS-C) remain poorly characterized. Here, we use next …
inflammatory syndrome in children (MIS-C) remain poorly characterized. Here, we use next …
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents
D Rivera-Pérez, C Méndez, B Diethelm-Varela… - Frontiers in …, 2024 - frontiersin.org
Background Vaccine effectiveness against SARS-CoV-2 infection has been somewhat
limited due to the widespread dissemination of the Omicron variant, its subvariants, and the …
limited due to the widespread dissemination of the Omicron variant, its subvariants, and the …
[HTML][HTML] Serologic responses to COVID-19 vaccination in children with history of multisystem inflammatory syndrome (MIS-C)
MA Perez, HM Hsiao, X Chen, A Kunkel, N Baida… - Vaccine, 2023 - Elsevier
Understanding the serological responses to COVID-19 vaccination in children with history of
MIS-C could inform vaccination recommendations. We prospectively enrolled seven children …
MIS-C could inform vaccination recommendations. We prospectively enrolled seven children …
Routine SARS‐CoV‐2 vaccination for all children
K De Paris, SR Permar - Immunological reviews, 2022 - Wiley Online Library
The SARS‐CoV‐2 pandemic has resulted in unprecedented health and economic losses.
Children generally present with less severe disease from this virus compared with adults, yet …
Children generally present with less severe disease from this virus compared with adults, yet …
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later
EC Milligan, K Olstad, CA Williams, M Mallory… - Science Translational …, 2022 - science.org
The US Food and Drug Administration only gave emergency use authorization of the
BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines for infants 6 months and older in June …
BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines for infants 6 months and older in June …